Send me a link:

*Text messaging rates may apply.

 Dow Down 0.14% Nasdaq Up 0.12%

Oncothyreon Inc (ONTY)

-NasdaqGS
2.64 Down 0.09(3.30%) 12:08PM EDT - Nasdaq Real Time Price
Prev Close:2.73
Open:2.74
Bid:2.66 x 500
Ask:2.67 x 1200
1y Target Est:5.33
Beta:1.31
Next Earnings Date:N/A
Day's Range:2.64 - 2.74
52wk Range:1.57 - 4.08
Volume:81,111
Avg Vol (3m):558,679
Market Cap:186.77M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ONTY

Comparison

Symbol% ChgMkt Cap
ONTYDown 3.30%186.77M
GSKDown 1.25%129.30B
RHHBYUp 0.03%250.43B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.48
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback